tiprankstipranks
Blurbs

Analysts Conflicted on These Healthcare Names: Sanofi (OtherSNYNF) and Boston Scientific (BSX)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Sanofi (SNYNFResearch Report) and Boston Scientific (BSXResearch Report).

Sanofi (SNYNF)

In a report issued on February 22, Emmanuel Papadakis from Deutsche Bank maintained a Sell rating on Sanofi, with a price target of EUR80.00. The company’s shares closed last Monday at $100.03.

According to TipRanks.com, Papadakis is a 3-star analyst with an average return of 2.8% and a 53.4% success rate. Papadakis covers the Healthcare sector, focusing on stocks such as Roche Holding AG, Novo Nordisk, and Moderna.

Sanofi has an analyst consensus of Moderate Buy, with a price target consensus of $117.66.

See Insiders’ Hot Stocks on TipRanks >>

Boston Scientific (BSX)

In a report issued on March 3, Pito Chickering from Deutsche Bank maintained a Hold rating on Boston Scientific, with a price target of $45.00. The company’s shares closed last Tuesday at $43.74.

According to TipRanks.com, Chickering is a 4-star analyst with an average return of 8.7% and a 58.1% success rate. Chickering covers the Healthcare sector, focusing on stocks such as Zimmer Biomet Holdings, Edwards Lifesciences, and Baxter International.

Boston Scientific has an analyst consensus of Strong Buy, with a price target consensus of $49.91.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on SNYNF:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More